Epigenetics Global and Regional Market Analysis: A $14,311.1 Million Market by 2031, Growing at a CAGR of 17% During 2021-2031
February 21, 2022 04:08 ET
|
Research and Markets
Dublin, Feb. 21, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market - A Global and Regional Analysis: Focus on Product, Mechanism, Technology, Application, End User, and Region - Analysis and...
Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational 2022 Virtual Conference
February 17, 2022 08:01 ET
|
Salarius Pharmaceuticals, Inc.
HOUSTON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas,...
Salarius Pharmaceuticals to Participate in the 2022 BIO CEO & Investor Conference
February 08, 2022 08:00 ET
|
Salarius Pharmaceuticals, Inc.
HOUSTON, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas,...
Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
December 15, 2021 08:31 ET
|
Salarius Pharmaceuticals, Inc.
HOUSTON, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas,...
Salarius Pharmaceuticals to Participate in Annual Benchmark Company Discovery One-on-One Conference
November 29, 2021 08:01 ET
|
Salarius Pharmaceuticals, Inc.
HOUSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas,...
Inherent Biosciences Launches Path Fertility - Epigenetic Sperm Quality Test (SpermQT)
October 18, 2021 09:12 ET
|
Inherent Biosciences Inc
SALT LAKE CITY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Inherent Biosciences, a molecular diagnostics company at the intersection of epigenetics and artificial intelligence (AI), today announced the...
Proteintech Expands Collaboration With Epigenetics Company Active Motif
September 08, 2021 16:55 ET
|
Proteintech Group Inc.
ROSEMONT, Ill., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic...
CRISPR and Cas Genes Markets, 2028 by Product & Service (Vector-based Cas, DNA-free Cas), Application (Biomedical, Agriculture)
June 16, 2021 06:08 ET
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application...
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
June 11, 2021 09:00 ET
|
Constellation Pharmaceuticals , Inc.
Translational data support the disease-modifying potential of pelabresibCentral pathology review confirmed bone marrow fibrosis improvements observed with pelabresib treatment Impact of pelabresib...
Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 31, 2021 09:00 ET
|
Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., May 31, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover...